Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

NCT03362177 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Thrombocytopenia

Interventions

BIOLOGICAL: Romiplostim
OTHER: Placebo

Sponsor

Amgen